Legal Representation
Attorney
Maryann E. Licciardi
USPTO Deadlines
Next Deadline
2025 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-28)
Due Date
January 28, 2031
Grace Period Ends
July 28, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 eventsDate | Code | Type | Description |
---|---|---|---|
Jan 28, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Jan 28, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Dec 10, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Dec 10, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
Dec 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Nov 14, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Oct 31, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Oct 31, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 31, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Oct 17, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Oct 17, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Oct 17, 2024 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Oct 17, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Oct 17, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Oct 17, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Aug 11, 2024 | RFNT | P | REFUSAL PROCESSED BY IB |
Jul 22, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU |
Jul 22, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Jun 27, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Jun 26, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Apr 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Oct 24, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Oct 20, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Oct 19, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
BIOLOGICAL PREPARATIONS FOR THE TREATMENT OF CANCER AND HEREDITARY DISEASES; DIAGNOSTIC REAGENTS FOR CLINICAL MEDICAL OR CLINICAL LABORATORY USE
Class 040
CONTRACT MANUFACTURING OF PHARMACEUTICALS IN THE FIELD OF BIOCHEMICALS AND VIRAL VECTORS
Class 042
Development of new technology for others in the field of drug discovery and validation, gene expression and delivery, genomics research
Classification
International Classes
005
040
042
USPTO Documents
Loading USPTO documents...